These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38971334)

  • 1. BI-7273, a BRD9 inhibitor, reduces lipid accumulation by downregulating the AKT/mTOR/SREBP1 signaling pathway.
    Li Y; He Q; Chen S; Dli H; Zhao J; Sun X; Yang P; Mao Q; Xia H
    Biochem Pharmacol; 2024 Aug; 226():116412. PubMed ID: 38971334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
    Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro.
    Ren L; Wang R; Wang Y; Tie F; Dong Q; Wang H; Hu N
    J Ethnopharmacol; 2024 Dec; 335():118657. PubMed ID: 39127115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
    J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1.
    Zhou JP; Ren YD; Xu QY; Song Y; Zhou F; Chen MY; Liu JJ; Chen LG; Pan JS
    Biomed Res Int; 2020; 2020():4087928. PubMed ID: 31998789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
    Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K/Akt/mTOR signaling pathway.
    Chen M; Li H; Zheng S; Shen J; Chen Y; Li Y; Yuan M; Wu J; Sun Q
    Phytomedicine; 2024 Jun; 128():155360. PubMed ID: 38547624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterol Regulatory Element Binding Protein 1: A Mediator for High-Fat Diet-Induced Hepatic Gluconeogenesis and Glucose Intolerance in Fish.
    Zhao Z; Xiang X; Chen Q; Du J; Zhu S; Xu X; Shen Y; Wen S; Li Y; Xu W; Mai K; Ai Q
    J Nutr; 2024 May; 154(5):1505-1516. PubMed ID: 38460786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
    Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C
    Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet.
    Hao T; Chen H; Wu S; Tian H
    Mol Med Rep; 2019 Jul; 20(1):701-708. PubMed ID: 31180545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.
    Li T; Weng J; Zhang Y; Liang K; Fu G; Li Y; Bai X; Gao Y
    Cell Death Dis; 2019 Aug; 10(8):619. PubMed ID: 31409773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro.
    Wei D; Wu S; Liu J; Zhang X; Guan X; Gao L; Xu Z
    Can J Physiol Pharmacol; 2021 Aug; 99(8):775-785. PubMed ID: 33290156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1.
    Han J; Li E; Chen L; Zhang Y; Wei F; Liu J; Deng H; Wang Y
    Nature; 2015 Aug; 524(7564):243-6. PubMed ID: 26147081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.